Healthcare
Heartflow, Inc. Common Stock(HTFL)
Live Price
Offline$33.84
+0.59% today
Window Change
+21.43%
Window
Aug 8, 2025 โ Jun 24, 2026
- Market Cap
- $2.55B
- Revenue Growth
- +39.9%
- EPS Growth
- +8.1%
- Dividend Yield
- 0.0%
Coverage: 219 bars ยท Aug 8, 2025 โ Jun 24, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Heartflow, Inc. Common Stock (HTFL) is a Healthcare stock with a market cap of $2.55B and listed on NASDAQ. The stock last traded around $33.84 and up 21.4% across the available one-year price window (Aug 8, 2025 โ Jun 24, 2026). Baseline metrics include revenue growth of +39.9%, EPS growth of +8.1%, a dividend yield of 0.0%. What stands out right now is revenue +39.9%, EPS +8.1%, free cash flow +19.5% with operating margin -36.4% and ROIC -19.8%. Valuation already assumes a fairly strong business story at price/sales 14.5. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines HTFL price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+39.9% vs +7.6% peer median
Operating Margin
Below sector median
-36.4% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on Jun 17, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +39.9% and EPS at +8.1%, with operating margin around -36.4%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -7.4% over the next 5 trading days and finished higher after 1 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Jun 17, 2026 | โ | +2.4% | โ | โ |
2026 Mar 18, 2026 | +30.9% | +1.6% | +9.0% | +17.0% |
2025 Nov 12, 2025 | -35.0% | -13.4% | -23.8% | -20.7% |
Benchmark Edge
HTFL vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
HTFL
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
HTFL Max Drawdown
-48.66%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for HTFL and SPY.
Company Overview
Heartflow, Inc. Common Stock
NASDAQ Global Select
HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries. The company's platform provides insights on blood flow, stenosis, and plaque volume and composition by overcoming the limitations of traditional non-invasive imaging tests. The company was founded in 2007 and is headquartered in Mountain View, California.
- Leadership
- John Farquhar
- IPO Date
- Aug 7, 2025
- Employees
- 626
- Street Address
- 331 E. Evelyn Avenue
- Mailing
- Mountain View, CA, 94041
- Region
- Mountain View, CA, US
- Reporting Currency
- USD
- Investor Line
- 650-241-1221
- Last Updated
- Apr 30, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- 14.5
- Price/Book
- 36.5
Growth
- Revenue
- +39.9%
- EPS
- +8.1%
- Free Cash Flow
- +19.5%
Profitability
- Gross Margin
- 76.8%
- Operating Margin
- -36.4%
- Net Margin
- -66.3%
- ROE
- 38.0%
- ROIC
- -19.8%
Balance Sheet
- Debt/Equity
- 0.07
- Current Ratio
- 5.20
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.